The addition of vildagliptin to metformin prevents the elevation of interleukin 1ß in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study

被引：0
作者：
Arwa Younis
Dana Eskenazi
Ronen Goldkorn
Jonathan Leor
Nili Naftali-Shani
Enrique Z. Fisman
Alexander Tenenbaum
Ilan Goldenberg
Robert Klempfner
机构：
[1] Sheba Medical Center,The Leviev Heart Center
[2] Tel Aviv University,Sackler School of Medicine
[3] Cardiovascular Diabetology Research Foundation,Heart Research Follow
[4] University of Rochester,up Program
来源：
Cardiovascular Diabetology | / 16卷
关键词：
Interleukin 1 beta; Vildagliptin; Dipeptidyl peptidase-4 inhibitors; Gliptins; Metformin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study [J].
Filozof, C. ;
Gautier, J. -F. .
DIABETIC MEDICINE, 2010, 27 (03) :318-326
[22]   Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study [J].
Althobaiti, Fahad M. ;
Alsanosi, Safaa M. ;
Falemban, Alaa H. ;
Alzahrani, Abdullah R. ;
Fataha, Salma A. ;
Salih, Sara O. ;
Alrumaih, Ali M. ;
Alotaibi, Khalid N. ;
Althobaiti, Hazim M. ;
Al-Ghamdi, Saeed S. ;
Ayoub, Nahla .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
[23]   Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study [J].
Christine Berndt-Zipfel ;
Georg Michelson ;
Markus Dworak ;
Michael Mitry ;
Andrea Löffler ;
Andreas Pfützner ;
Thomas Forst .
Cardiovascular Diabetology, 12
[24]   Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study [J].
Berndt-Zipfel, Christine ;
Michelson, Georg ;
Dworak, Markus ;
Mitry, Michael ;
Loeffler, Andrea ;
Pfuetzner, Andreas ;
Forst, Thomas .
CARDIOVASCULAR DIABETOLOGY, 2013, 12
[25]   Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study [J].
Liu, S-C ;
Lee, C-C ;
Chuang, S-M ;
Sun, F-J ;
Zeng, Y-H .
DIABETES & METABOLISM, 2021, 47 (03)
[26]   Adding metformin versus insulin dose increase in insulin-treated but poorly controlled type 2 diabetes mellitus: an open-label randomized trial [J].
Relimpio, F ;
Pumar, A ;
Losada, F ;
Mangas, MA ;
Acosta, D ;
Astorga, R .
DIABETIC MEDICINE, 1998, 15 (12) :997-1002
[27]   Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial [J].
Abe, Tomoe ;
Takeda, Yasutaka ;
Sakuma, Ichiro ;
Okada, Mizuho ;
Kurigaki, Ayaka ;
Bessho, Ryoichi ;
Sato, Mao ;
Kitsunai, Hiroya ;
Takiyama, Yumi ;
Sakurai, Masaru .
METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (09) :651-660
[28]   Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study [J].
Seino, Y. ;
Miyata, Y. ;
Hiroi, S. ;
Hirayama, M. ;
Kaku, K. .
DIABETES OBESITY & METABOLISM, 2012, 14 (10) :927-936
[29]   Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study) [J].
Koshizaka, Masaya ;
Ishikawa, Ko ;
Ishibashi, Ryoichi ;
Maezawa, Yoshiro ;
Sakamoto, Kenichi ;
Uchida, Daigaku ;
Nakamura, Susumu ;
Yamaga, Masaya ;
Yokoh, Hidetaka ;
Kobayashi, Akina ;
Onishi, Shunichiro ;
Kobayashi, Kazuki ;
Ogino, Jun ;
Hashimoto, Naotake ;
Tokuyama, Hirotake ;
Shimada, Fumio ;
Ohara, Emi ;
Ishikawa, Takahiro ;
Shoji, Mayumi ;
Ide, Shintaro ;
Ide, Kana ;
Baba, Yusuke ;
Hattori, Akiko ;
Kitamoto, Takumi ;
Horikoshi, Takuro ;
Shimofusa, Ryota ;
Takahashi, Sho ;
Nagashima, Kengo ;
Sato, Yasunori ;
Takemoto, Minoru ;
Newby, Laura Kristin ;
Yokote, Koutaro .
DIABETES OBESITY & METABOLISM, 2019, 21 (08) :1990-1995
[30]   Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes [J].
Shunsuke Yamazaki ;
Tatsuro Takano ;
Koji Tachibana ;
Soichiro Takeda ;
Yasuo Terauchi .
Diabetes Therapy, 2022, 13 :1559-1569
12345